Normaflore Extra (Bacillus Clausii)

Bacillus clausii spores survive the acidic environment of the stomach, reach the intestine and temporarily colonize the mucosa. There they compete with harmful bacteria, produce antimicrobial substances, and modulate local immune responses, which together help reduce pathogenic overgrowth and support a balanced microbiota.

The appropriate dose of Normaflore Extra is determined by the prescribing healthcare professional based on the patient’s age, condition and clinical response. Patients should follow the specific instructions provided by their prescriber or pharmacist.

Safety data for Bacillus clausii in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Normaflore Extra with their healthcare provider before starting treatment.

To order Normaflore Extra, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Normaflore Extra contains the specific strain Bacillus clausii, which is known for its ability to survive gastric acidity and produce antimicrobial substances. Compared with lactobacilli‑based probiotics, Bacillus clausii may offer a broader spectrum of activity against certain pathogens and is often used for antibiotic‑associated diarrhoea.

Normaflore Extra should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and avoid exposure to extreme heat or humidity to maintain bacterial viability.

Normaflore Extra is taken orally. The exact method—such as swallowing capsules, mixing a powder with water, or using a suspension—depends on the formulation supplied and the instructions given by the prescriber. It is typically taken with or without food as directed.

The most serious risks, although rare, include systemic infection (sepsis) in severely immunocompromised individuals and allergic reactions that may manifest as rash, itching, swelling or respiratory difficulty. Patients should seek immediate medical attention if such symptoms occur.

Normaflore Extra should be avoided in patients with known hypersensitivity to Bacillus clausii or any excipients in the product. It is also contraindicated in severely immunocompromised patients unless specifically recommended by a specialist, and in infants younger than one month without medical supervision.